Cathie Wood’s ARK Invest Sells Over 690,000 Shares of Takeda Pharma
One of Cathie Wood's Ark Invest funds sold over 690,000 shares of Takeda Pharmaceutical on November 16.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 690,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK | TAK Price Prediction) on Tuesday, as the share price of this fund traded was up 2% in the day’s session. Its share price has greatly improved over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 692,660 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $9.8 million. This is only a small fraction of the total holdings. This fund is flat over the past 52 weeks.
[nativounit]
Here is a quick look at all the other sales that took place across all ARK ETFs:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | OPEN | OPENDOOR TECHNOLOGIES | 166,353 |
| ARKF | Z | ZILLOW | 123,790 |
| ARKG | INCY | INCYTE | 6,219 |
| ARKG | TAK | TAKEDA PHARMACEUTICAL | 692,660 |
| ARKG | VEEV | VEEVA SYSTEMS | 31,755 |
| ARKQ | LMT | LOCKHEED MARTIN | 4,885 |
| ARKQ | U | UNITY SOFTWARE | 11,000 |
| ARKW | U | UNITY SOFTWARE | 112,381 |
| ARKX | HOFP | THALES | 15,040 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
[recirclink id=994210][wallst_email_signup]
Contact [email protected] for any questions or corrections.








